Infection Control and prevention: A review of hospital-acquired infections and the economic implications

Ochsner Journal

Volumn 9, Issue 1, 2009, Pages 27-31

  Reed, Deoine ^a   Kemmerly, Sandra A ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Economics; Finance; Healthcare; Hospital acquired infection; Infection control; Infection prevention

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CATHETER INFECTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CORONARY ARTERY BYPASS GRAFT; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; ENTEROCOCCAL INFECTION; FUNDING; HAND WASHING; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL; HOSPITAL INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INTRAVASCULAR CATHETER; MEDIASTINITIS; MEDICAL SOCIETY; MEDICARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PERINEAL CARE; REIMBURSEMENT; REVIEW; REWARD; SURGICAL INFECTION; THROMBOSIS PREVENTION; UNITED STATES; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 65749109776     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Organisation for Economic Co-operation and Development, OECD Health Data 2006. From the OECD Internet subscription database updated October 10, 2006. Copyright OECD 2006, http://www.oecd.org/health/healthdata.
2. National Center for Health Statistics. (2002) Health, United States, 2002 with Chartbook on Trends in the Health of Americans, Table 32. In: JW Henderson, ed. Health Economics and Policy. 3rd ed. Boston: Cenage Learning;2005.
3. Healthcare-Associated Infection Working Group of the Joint Public Policy Committee, Essentials of Public Reporting of Healthcare- Associated Infections: A Tool Kit. Centers for Disease Control and Prevention Web site, http://www.cdc.gov/ncidod/dhqp/pdf/ar/06-107498-EssentiaIs-Tool-Kit.pdf. Accessed Jan 16, 2009.
4. Chaudhuri AK. Infection control in hospitals: has its qualityenhancing and cost-effective role been appreciated? J Hosp Infect. 1993;25 (1) :1-6.
5. Hughes JH. Study on the efficacy of nosocomial infection control (SENIC Project) : results and implications for the future. Chemotherapy. 1988;34 (6) :553-561.
6. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network Report, data summary for 2006, issued June 2007. Am J Infect Control. 2007;35 (9) :290-301.
7. Stone PW, Braccia D, Larson E. Systemic review of economic analyses of health care-associated infections. Am J Infect Control. 2005;33 (9) :501-509.
8. Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28 (10) :1121-1133.
9. Jarvis WR, Schlosser J, Chinn RY, Tweeten S, Jackson M. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control. 2007;35 (10) :631-637.
10. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005;26 (2) :175-183. (Pubitemid 40445023)
11. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36 (5) :592-598; Epub 2003 Feb. 7. (Pubitemid 36259564)
12. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis. 1992;166 (3) :561-567.
13. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320 (4) :204-210.
14. Kyne L, Hamel MB, Polavaram R, Kelly CP. Healthcare costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34 (3) :346-353; Epub 2001 Dec. 17.
15. Salgado CD, Farr BM. Outcomes associated with vancomycinresistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol. 2003;24 (9) :690-698.
16. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes related to VRE [abstract]. 40th Interscience Conference Antimicrobial Agents and Chemotherapy. 2000;40 (Suppl. 1) :Abstract 431.
17. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis. 2004;10 (4) :561-566. (Pubitemid 38420284)